Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay.

Journal Information

Full Title: Front Endocrinol (Lausanne)

Abbreviation: Front Endocrinol (Lausanne)

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest DT, BH, FJC, PR, DS, and C-tT were employed by Enable Biosciences. FJC, DT, PR, DS, and C-tT are shareholders of Enable Biosciences. PR and C-tT are inventors of the ADAP patent licensed from University of California, Berkeley to Enable Biosciences. The ADAP assay used in this study is a product in development. This does not alter our adherence to journal policies on sharing data and materials."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported in part by the JDRF RSC-2022-1102-M-N to Enable Biosciences. This work was supported in part by the NIH SBIR 2R44DK110005-02 to Enable Biosciences. DT, BH, JC, PR, DS, and C-tT were supported by the JDRF and NIH grants above."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025